Adolescents with HIV and facial lipoatrophy: response to facial stimulation by Gabana-Silveira, Jesus Claudio et al.
Adolescents with HIV and facial lipoatrophy:
response to facial stimulation
Jesus Claudio Gabana-Silveira,I Laura Davison Mangilli,II Fernanda C. Sassi,II Arnaldo Feitosa Braga,III
Claudia Regina Furquim AndradeII
I Fundac¸a˜o de Protec¸a˜o Especial do Rio Grande do Sul, Porto Alegre/RS, Brazil. II Faculdade de Medicina da Universidade de Sao Paulo, Physiotherapy,
Speech-Language and Hearing Sciences, and Occupational Therapy, Sao Paulo/SP, Brazil. IIIUniversidade Estadual do Rio de Janeiro, Microbiology,
Immunology and Parasitology, Rio de Janeiro/RJ, Brazil.
OBJECTIVES: This study evaluated the effects of facial stimulation over the superficial muscles of the face in
individuals with facial lipoatrophy associated with human immunodeficiency virus (HIV) and with no indication
for treatment with polymethyl methacrylate.
METHOD: The study sample comprised four adolescents of both genders ranging from 13 to 17 years in age. To
participate in the study, the participants had to score six or less points on the Facial Lipoatrophy Index. The
facial stimulation program used in our study consisted of 12 weekly 30-minute sessions during which individuals
received therapy. The therapy consisted of intra- and extra-oral muscle contraction and stretching maneuvers of
the zygomaticus major and minor and the masseter muscles. Pre- and post-treatment results were obtained
using anthropometric static measurements of the face and the Facial Lipoatrophy Index.
RESULTS: The results suggest that the therapeutic program effectively improved the volume of the buccinators.
No significant differences were observed for the measurements of the medial portion of the face, the lateral
portion of the face, the volume of the masseter muscle, or Facial Lipoatrophy Index scores.
CONCLUSION: The results of our study suggest that facial maneuvers applied to the superficial muscles of the
face of adolescents with facial lipoatrophy associated with HIV improved the facial area volume related to the
buccinators muscles. We believe that our results will encourage future research with HIV patients, especially for
patients who do not have the possibility of receiving an alternative aesthetic treatment.
KEYWORDS: Speech; Language and Hearing Sciences; HIV; Associated Lipodystrophy Syndrome; Therapeutics.
Gabana-Silveira JC, Mangilli LD, Sassi FC, Braga AF, Andrade CR. Adolescents with HIV and facial lipoatrophy: response to facial
stimulation. Clinics. 2014;69(8):574-578.
Received for publication on December 3, 2013; First review completed on January 14, 2014; Accepted for publication on February 21, 2014
E-mail: clauan@usp.br
Tel.: 55 11 3091-8406
& INTRODUCTION
The increased survival experienced by human immuno-
deficiency virus (HIV) infected patients after the advent of
highly effective antiretroviral therapies has been accompa-
nied by the frequent occurrence of chronic metabolic
abnormalities, such as HIV-related lipodystrophy (1-5).
Facial lipoatrophy associated with HIV has become epi-
demic and can be cosmetically disfiguring (6). The observed
symptoms are peripheral fat wasting with a loss of
subcutaneous tissue on either side of the face (temporal
and maxillary wasting) (Figure 1). These physical symptoms
might stigmatize the individual as one living with HIV
infection, a worrisome complication due to its negative
psychological impact on mood, self-esteem and adherence
to treatment (2). The purpose of the present study was to
verify the effects of facial stimulation through maneuvers
that promote muscle contraction and stretching over the
superficial muscles of the face of adolescents with facial
lipoatrophy associated with HIV and no indication for
treatment with polymethyl methacrylate (PMMA) infiltra-
tion.
& MATERIALS AND METHODS
An observational, descriptive case study was conducted
with adolescents with HIV. The study design was approved
by the Ethics Committee for the Analysis of Research
Projects (CEP-HUPE no. 2411). Prior to enrollment, all
participants were informed of the purpose and procedures
and all participants provided their informed consent.
The initial study sample was composed of nine adoles-
cents of both genders ranging from 13 to 17 years in age. The
individuals were recruited from a Brazilian HIV Program
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Treatment Center that offers free and universal access to
antiretroviral therapy. The participants were eligible if they
met the following criteria: received a medical diagnosis of
HIV acquired through mother/child transmission; were
receiving continuous retroviral therapy; presented an
undetectable viral load; did not previously receive PMMA
infiltration treatment; scored six or less points on the Facial
Lipoatrophy Index (FLI) (6); and presented no history of
head and neck trauma or surgery. According to Brazilian
legislation, although the use of PMMA for treating facial
lipoatrophy associated HIV is indicated for individuals
above 12 years of age, there is a national consensus that this
material should be used with caution in adolescents.
Craniofacial development can still be observed in adoles-
cents and can occur until the end of this phase (i.e.,
approximately 18 years of age) (7). The use of permanent
fillers for aesthetic purposes is recommended only after
craniofacial growth has ended to avoid new surgical
interventions and new aesthetic procedures. Of the nine
patients who were referred for facial stimulation therapy,
only four completed the treatment proposal (Figure 2).
To avoid possible variations in the applied therapy
techniques, all of the participants were assessed and treated
by the same speech-language pathologist (SLP). The SLP
performing the facial assessment and delivering treatment
successfully passed specific training tests.
The treatment effects were assessed pre- and post-
treatment using the following measurements:
1. Anthropometric measurement of the face (8,9);
2. Facial Lipoatrophy Index (FLI) (6).
Anthropometry is the biological science of measuring the
size, weight and proportion of the human body (8) and
provides objective data regarding craniofacial morphology
through a series of head and face measurements (10). For
the present study, we selected the following static measure-
ments (Figure 3: The images presented are from one of the
participants): (a) medial portion of the face – the diagonal
distance from the external corner of the eye to the
commissure (mouth); (b) lateral portion of the face – the
diagonal distance from the tragus (ear) to the end point of
the nasolabial fold projection on the mandible (i.e.,
measurements a and b estimate the volumes of the
buccinator and masseter muscles, respectively); (c) masseter
muscles– the horizontal distance from the center of the left
masseter to the center of the right masseter (the muscle
center point is estimated by asking the patient to clench
their teeth to produce muscle contraction and determined
by palpation of the region with maximal volume); (d)
buccinators muscles - the horizontal distance from the
center of the left buccinator to the center of the right
buccinator (muscle center point is determined by measuring
the midpoint between the external corner of the eye and the
commissure).
The measurements were performed using a digital caliper
(Digimess, Pro´-Fono). The individuals were examined while
sitting on a chair with their heads positioned horizontally
according to the Frankfort plane. Prior to performing the
measurements, the landmarks were identified on the face
Figure 1 - patient with facial lipoatrophy associated with HIV.
Figure 2 - Sample characterization.
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using a marking pen. The measurements of each location
were repeated to ensure reliability. However, if a difference
greater than 25% was observed among any set of measure-
ments, the data were collected again.
The FLI (6) is a clinical evaluation developed by Brazilian
doctors that aims to estimate the levels of facial atrophy and
improvement with treatment. The FLI evaluates three facial
regions separately (i.e., malar, temporal and pre-auricular
regions) and the score ranges from 0 to 20 points. To
determine the level of atrophy, two characteristics (depth
and extension) of facial atrophy are observed. The depth of
atrophy is graded from 0 to 4 (0, absence of atrophy; 1, mild;
2, moderate; 3, severe; 4, very severe). The extension of the
involved area is graded from 0 to 5 (0, absence of
involvement; 1, less than 20% involvement; 2, 21 to 50%
involvement; 3, 51-70% involvement; 4, 71 to 90% involve-
ment; 5, 91 to 100% involvement).
A partial number is calculated for each evaluated area,
and then each number is multiplied by the depth grading of
the involved area and by a correction factor. The correction
factor was specified for each facial region and corresponds
to the level of importance of each region for facial atrophy.
The following correction factors were used: 0.7 for the malar
region, 0.2 for the temporal region and 0.1 the pre-auricular
region. The partial grades of the three regions are added to
determine the final grade. Given that the loss of fat is not
symmetrical, the side of the face that is mostly compromised
determines the final score on the FLI. Based on the FLI, the
Brazilian Ministry of Health (11) classifies facial lipoatrophy
from levels I to IV: Level I (mild facial atrophy), 0 to 5.9 on
the FLI; Level II (moderate facial atrophy), 6.0 to 10.0 on the
FLI; Level III (severe facial atrophy), 10.1 to 15 on the FLI;
Level IV (very severe facial atrophy), 15.1 to 20 on the FLI.
The Ministry of Health recommends medical treatment for
HIV patients with facial lipoatrophy only when they present
with 6 or more points on the FLI.
After the initial evaluation, all of the participants under-
went a facial stimulation treatment program (12-15). The
treatment program, which formed an integral part of the
current study, consisted of 12 weekly 30-minutes sessions.
The individuals each received therapy, which included:
1. Intra- and extra-oral muscle contraction and stretching
maneuvers of the zygomaticus major and minor and the
masseter muscles (16-18);
2. Individuals were strongly encouraged to perform the
presented muscle contractions and stretching maneuvers
three times a day outside the clinic environment. Practice
consisted of four series of eight repetitions for each
maneuver. Participants were instructed to maintain a
diary to record their compliance with the given instruc-
tions.
Four participants completed the intervention program
and both evaluations. The results from these individuals
were considered for statistical analyses. The Shapiro-Wilk
test indicated that the data followed a normal and
homogeneous distribution. For this reason, the paired
Figure 3 - Anthropometric measures: A=medial portion of the face; B= lateral portion of the face; C =masseter; D=buccinators.
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Student’s t-test was used for pre- and post-treatment
comparisons (p,0.05).
& RESULTS
The results are presented in Table 1. The data analyses
indicated significant pre- and post-treatment variations for
the buccinator measurements. No significant differences
were observed for the other comparisons.
& DISCUSSION
Body image changes can be extremely disturbing to a
person’s psychosocial well-being and might enhance the
stigma of living with HIV (6). Additionally, body image
changes can trigger disturbances in social relations, leading
to the social isolation of the patient (2,19). Facial lipoatrophy
has a large psychological impact and can reduce the
patient’s complacency with the treatment (6).
The results of our study suggest that facial maneuvers
applied to the superficial muscles of the face of adolescents
with facial lipoatrophy associated with HIV improved the
volume of the facial area related to the buccinators. The
body of literature on motor behaviors indicates that motor
patterns are mediated by central neuronal circuits known as
Central Pattern Generators (CPGs). Currently, several CPGs
are under analysis. The literature has suggested a large
amount of variability in the cell and synaptic properties and
that different neuronal networks are interrelated to produce
the final characteristics of movements (20-23). Peripheral
orofacial sensory inputs can alter the excitability of the
inferior facial motor neurons and can contribute to move-
ment control. When applying training exercises/muscle
maneuvers, it is important to know that modifications in
strength are generally the result of modifications in how the
nervous system activates the muscle rather than structural
alterations in the muscle itself (24,25). The current evidence
suggests that the neuromotor system can suffer modifica-
tions due to experiences and that restructuring can either
occur at the central or peripheral level (24).
Although our study has limitations due to sample size,
we strongly believe that our results will encourage future
research with HIV patients, especially those who live with
the stigma of HIV and do not have the opportunity to
receive an alternative aesthetic treatment. Since anthropo-
metry cannot measure regional fat, we suggest the use of
more objective measurements, such as ultrasound, to
measure the absolute values of regional fat. To our knowl-
edge, this is the first study to investigate whether the facial
appearance of patients with lipoatrophy associated with
HIV can be improved.
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